Syntara Ltd (ASX:SNT)
A$ 0.033 -0.001 (-2.94%) Market Cap: 42.59 Mil Enterprise Value: 39.30 Mil PE Ratio: 0 PB Ratio: 8.25 GF Score: 0/100

Pharmaxis Ltd COVID-19 response Transcript

Nov 12, 2020 / 10:59 AM GMT
Release Date Price: A$0.1 (+11.11%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SNT.AX - Syntara Ltd
Pharmaxis Ltd COVID-19 response
Nov 12, 2020 / NTS GMT

=====================
Corporate Participants
=====================
* Fiona Fox
Acquisdata Inc. - Product Development Manager
* Gary Phillips
Pharmaxis Ltd - CEO

=====================
Questions and Answers
--------------------------------------------------------------------------------
Fiona Fox, Acquisdata Inc. - Product Development Manager [1]
--------------------------------------------------------------------------------
Well, Gary, it's been about six weeks, I think, since Australia locked down in response to the COVID-19 outbreaks, which had been declared a public health emergency of international concern by the WHO on the 30, January, it was, and characterised as a pandemic on the 11, March. So, what impact, Gary, has the virus and the response to it had on Pharmaxis operations and its current products and also its product in the pipeline?

----------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot